Emerging Biomarker Landscape In Gastro/Gastroesophageal Cancer Medical Industry Feature podcast

Konten disediakan oleh ReachMD. Semua konten podcast termasuk episode, grafik, dan deskripsi podcast diunggah dan disediakan langsung oleh ReachMD atau mitra platform podcast mereka. Jika Anda yakin seseorang menggunakan karya berhak cipta Anda tanpa izin, Anda dapat mengikuti proses yang diuraikan di sini https://id.player.fm/legal.

Medical Industry Feature »
Emerging Biomarker Landscape in Gastro/Gastroesophageal Cancer

2d ago

MP3•Beranda episode

Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Steven Maron, MD, MSc
Given the recent identification of actionable biomarkers like PD-L1 and MSI-H,^1-3 it’s important to test patients with gastroesophageal cancer for these biomarkers as they may provide insights into options for a patient’s treatment plan.^4,5 To learn more about how we can detect biomarkers and other key considerations for biomarker screening in gastroesophageal cancer, Dr. Charles Turck speaks with Dr. Steven Maron, a gastrointestinal oncologist at Memorial Sloan Kettering Cancer Center in New York.

References:

The Cancer Genome Atlas Network. Nature. 2014;513:202-209.
Fontana E, et al. Ther Adv Med Oncol. 2016;8:113-125.
Yang B, et al. J Exp Clin Cancer Res. 2019;38:283.
American Cancer Society. https://www.fightcancer.org/sites/default/files/Improving%20Access%20to%20Biomarker%20Testing_FINAL.pdf. Accessed July 20, 2024.
Catenacci DVT, et al. Future Oncol. 2019;15:2073-2082.

32 episode

#Science #Health and Well-Being #Medicine #Pediatrics #Nutrition #ReachMD